Completed OBSERVATIONAL NCT06967233
Multimodal Managements for Metastatic Pancreatic Cancer.
Analysis of the Current Situation of Diagnosis and Treatment of Pancreatic Cancer: Multimodal Managements for Metastatic Pancreatic Cancer
Sponsor: Zhejiang University
Conditions
Metastatic Pancreatic Cancer
Interventions
Multimodal treatment
Updated 1 time since 2025 Last updated: May 10, 2025 Started: Jun 1, 2019 Primary completion: Dec 31, 2023 Completion: Apr 1, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This observational or N/A phase trial investigates Metastatic Pancreatic Cancer and is currently completed. Zhejiang University leads this study, which shows 1 recorded version since 2019 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
1 version recorded Completed
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Zhejiang University
Data source: Zhejiang University
For direct contact, visit the study record on ClinicalTrials.gov .